These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 37530949)

  • 21. Herpes Zoster and Postherpetic Neuralgia: Practical Consideration for Prevention and Treatment.
    Jeon YH
    Korean J Pain; 2015 Jul; 28(3):177-84. PubMed ID: 26175877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes zoster in outpatient departments of healthcare centers in India: a review of literature.
    Patki A; Vora A; Parikh R; Kolhapure S; Agrawal A; Dash R
    Hum Vaccin Immunother; 2021 Nov; 17(11):4155-4162. PubMed ID: 34520327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes zoster and postherpetic neuralgia.
    Johnson RW
    Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):21-6. PubMed ID: 20192714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual pattern and clinical characteristics of herpes zoster in immunocompetent children in a rural area.
    Gündoğdu M; Erden N; Karagun E; Acıpayam AŞF; Vural S
    Dermatol Ther; 2021 Jan; 34(1):e14570. PubMed ID: 33219711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical Manifestations of Herpes Zoster Associated with Complications in Children.
    Kang DH; Kwak BO; Park AY; Kim HW
    Children (Basel); 2021 Sep; 8(10):. PubMed ID: 34682110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
    Johnson RW; Wasner G; Saddier P; Baron R
    Drugs Aging; 2008; 25(12):991-1006. PubMed ID: 19021299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
    Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
    J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
    Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
    BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of the cost effectiveness of herpes zoster vaccination.
    Szucs TD; Pfeil AM
    Pharmacoeconomics; 2013 Feb; 31(2):125-36. PubMed ID: 23335045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How large could the public health impact of introducing recombinant zoster vaccination for people aged ≥50 years in five Latin American countries be?
    Han R; Gomez JA; de Veras B; Pinto T; Guzman-Holst A; Nieto J; van Oorschot DAM
    Hum Vaccin Immunother; 2023 Dec; 19(1):2164144. PubMed ID: 36821856
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public Knowledge, Attitude, and Practice Toward Herpes Zoster Vaccination in Saudi Arabia.
    Alleft LA; Alhosaini LS; Almutlaq HM; Alshayea YM; Alshammari SH; Aldosari MA; Alateeq FA
    Cureus; 2023 Nov; 15(11):e49396. PubMed ID: 38024085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genital Herpes Zoster as Possible Indicator of HIV Infection.
    Ljubojević Hadžavdić S; Kovačević M; Skerlev M; Zekan Š
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):337-338. PubMed ID: 30665486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.
    Meysman P; Ogunjimi B; Naulaerts S; Beutels P; Van Tendeloo V; Laukens K
    J Virol; 2015 Jan; 89(2):962-9. PubMed ID: 25355886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional factors in herpes zoster, postherpetic neuralgia, and zoster vaccination.
    Chen JY; Chang CY; Lin YS; Hu ML
    Popul Health Manag; 2012 Dec; 15(6):391-7. PubMed ID: 23088666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herpes zoster in eastern Saudi Arabia: clinical presentation and management.
    Alakloby OM; AlJabre SH; Randhawa MA; Alzahrani AJ; AlWunais KM; Bukhari IA
    J Drugs Dermatol; 2008 May; 7(5):457-62. PubMed ID: 18505138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella zoster: an update on current treatment options and future perspectives.
    Kim SR; Khan F; Ramirez-Fort MK; Downing C; Tyring SK
    Expert Opin Pharmacother; 2014 Jan; 15(1):61-71. PubMed ID: 24289750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteopathic Manipulative Treatment of Herpes Zoster Ophthalmicus/Postherpetic Neuralgia.
    Volokitin M; Izadi N; Myers R; Kane Diaw N; Milani S
    Cureus; 2021 May; 13(5):e14906. PubMed ID: 34113516
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile.
    Brosio F; Masetti G; Matteo G; Stefanati A; Gabutti G
    Infect Drug Resist; 2018; 11():1401-1411. PubMed ID: 30233219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.